Psychedelic therapy for anxiety and depression is a hot topic these days. You may have heard about it on Michael Pollan’s recent Netflix series, How to Change Your Mind. The series devotes each episode to a different psychedelic medicine including LSD, psilocybin, MDMA and mescaline. These four drugs all have their own benefits and drawbacks, similarly to ketamine. Let’s take a look at each drug’s legal status, safety concerns and indicated uses.
Ketamine can provide similar psychedelic effects to other drugs such as LSD, MDMA, psilocybin and mescaline and is used to treat some of the same mood disorders. What exactly is a psychedelic?
What really goes on in the brain when a patient undergoes ketamine therapy? Read on to find out.
In early 2019, an esketamine nasal spray was approved by the FDA for adults with treatment-resistant depression. Its FDA-approved uses were later expanded to include patients suffering from acute suicidal ideation. But what is esketamine, and how is it different from regular ketamine?
Ketamine is a powerful drug capable of profoundly affecting your mind and body. It has different effects at different doses.
The brain relies on specialized chemicals called neurotransmitters to communicate with the nervous system and body. Different neurotransmitters are involved in a wide array of functions, depending on which neural circuits they act on.
Psychedelic therapy is finally making a comeback, and its return as a viable treatment option is thanks to the tireless efforts of Amanda Feilding.
Microdosing is a common term that has become a part of the cultural vernacular. It is the practice of ingesting a very low dose of a psychedelic substance. A microdose is small enough that it does not impair “normal” functioning, but still has an effect.